VistaShares Artificial Intelligence Supercycle ETF

DiaMedica Therapeutics Announces Enrollment of 200th Patient in ReMEDy2 Phase 2/3 Acute Ischemic Stroke Trial

GuruFocus•3d ago

Micot Pharma Debuts MT200605 Huntington's Disease Research in a Poster Presentation at MDS 2026 and Expands Development into Neurodegenerative Diseases

GuruFocus•13d ago

5 ETF Areas That Have Nearly Doubled in First Nine Months of 2026

Zacks Investment Research•1mo ago

The VistaShares Artificial Intelligence Supercycle® ETF (AIS) Hits $1 Billion in Assets

GlobeNewsWire•1mo ago

Micot Pharma Reports Positive Operating Cash Flow and Advances Late-Stage Pipeline in 1H 2026

GuruFocus•1mo ago

This AI Fund Is Crushing QQQ, and Nvidia Is Barely 2% of It

24/7 Wall Street•1mo ago

NVIDIA Raises the Bar on AI Growth: AI ETFs to Win

Zacks Investment Research•1mo ago

AIS: After A 136% Gain, The Best AI Trade Goes Beyond Chips

Seeking Alpha•2mo ago

Micot Pharma's MT200605 Achieves Primary Endpoint in Phase II Trial, Novel Integrated Multi-stage Neuroprotection Mechanism to Be Presented at WSC 2026

GuruFocus•2mo ago